Results 101 to 110 of about 9,281 (210)

Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosis

open access: yesMultiple Sclerosis Journal - Experimental, Translational and Clinical, 2018
Background Optic neuritis (ON) is one of the common manifestations both in neuromyelitis-optica spectrum disorders (NMOSD) and in multiple sclerosis (MS).
Jindapa Srikajon   +5 more
doaj   +1 more source

NMOSD : Adaptive Immunity Revisited

open access: yesClinical and Experimental Neuroimmunology
ABSTRACT Accumulating evidence underscores the pivotal role of adaptive immunity in the pathogenesis of AQP4‐IgG‐positive neuromyelitis optica spectrum disorder (NMOSD). Autoreactive B cells produce pathogenic antibodies against aquaporin‐4 (AQP4), and their dysregulation is evident in both peripheral blood and cerebrospinal fluid ...
Ritsu Akatani, Norio Chihara
openaire   +1 more source

Identifizierung pathogener Signalwege der Neutrophile bei NMOSD und MOGAD [PDF]

open access: yes
Neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glyco-protein antibody-associated disease (MOGAD) are rare chronic demyelinating autoimmune disorders of the central nervous system (CNS).
Schroeder Castagno, Maria Eugenia
core   +1 more source

Neuromyelitis optica spectrum disorder with acute brainstem manifestations as initial symptoms

open access: yesHeliyon
Objective: To explore the clinical features and prognosis of patients with neuromyelitis optica spectrum disorder (NMOSD) initially presenting with acute brainstem symptoms.
Zhen Li   +3 more
doaj   +1 more source

Comparison of clinical features of aquaporin-4 positive neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein associated disorder (MOGAD), and double seronegative NMOSD - A single center experience

open access: yes
This retrospective study investigates Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD), Myelin Oligodendrocyte Glycoprotein Associated Disorder (MOGAD), and Seronegative NMOSD at a tertiary care university hospital, over a 13 ...
ACAR ÖZEN, NAZİRE PINAR   +6 more
core   +1 more source

Differences in disease burden between neuromyelitis optica spectrum disorder and multiple sclerosis in South China

open access: yesMultiple Sclerosis Journal - Experimental, Translational and Clinical
Background Neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) differ substantially in pathophysiological mechanisms, clinical manifestations and therapeutic management.
Xin Huang   +4 more
doaj   +1 more source

Neuromyelitis Optica Spectrum Disorder (NMOSD): Challenges and Updates

open access: yes
Pendahuluan: Neuromyelitis optica spectrum disorder (NMOSD) merupakan kondisi autoimun yang ditandai dengan inflamasi pada nervus optikus, saraf spinal, dan sistem saraf pusat.
Sidik, Mohamad   +3 more
core   +1 more source

Inebilizumab treatment in a patient with co-occurring AQP4-IgG positive neuromyelitis optica spectrum disorder and myasthenia gravis: a case report and literature review

open access: yesFrontiers in Immunology
ObjectiveThis study aims to delineate the clinical features underlying the concurrent disease of neuromyelitis optica spectrum disorder (NMOSD) and myasthenia gravis (MG), and to identify efficacious therapeutic strategies.BackgroundNMOSD and MG are ...
Xiaoqian Song   +6 more
doaj   +1 more source

Navigating Complexity in Pediatric NMOSD: Unusual Symptoms and Adverse Reactions: A Case Report

open access: yes
Background and Clinical Significance: Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune demyelinating disorder of the central nervous system, characterized by the presence of aquaporin-4 (AQP4) antibodies and a high relapse rate.
Oana-Aurelia Vladâcenco   +3 more
core   +1 more source

NMOSD patient depressive symptoms endorsed on BDI-II.

open access: yes
NMOSD patient depressive symptoms endorsed on BDI-II.
Chelsi N. Nurse (18275708)   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy